Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_assertion type Assertion NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_head.
- NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_assertion wasGeneratedBy ECO_0000203 NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_provenance.
- NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_assertion wasDerivedFrom befree-20140225 NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_provenance.
- NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_assertion SIO_000772 17007011 NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_provenance.
- NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_assertion evidence source_evidence_literature NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_provenance.
- NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_assertion description "[Notably, the recently described IL-23 shares the p40 subunit with IL-12, raising the possibility that the clinical benefit of the anti-IL-12/p40 antibody in CD may also be due to the neutralization of IL-23 activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302605.RASmtV-wCjlXDRKbym0SCxF-VyNcLjaNojt6NHdjGYzlc130_provenance.